The Journal of Organic Chemistry
Note
59.6, 29.5, 28.5, 25.8/25.7, 14.5, 14.4, 11.1 ppm; HRMS (ESI) [M +
H]+ calcd. for [C12H25N2O5] 277.1763, found 277.1766.
(400 MHz, CDCl3) δ 7.31 (brs, 15H), 6.53−6.24 (brm, 1H), 5.20−
4.96 (m, 4H), 4.54−4.38 (m, 3H), 3.68−3.38 (m, 4H), 1.97−1.27 (m,
4H) ppm; 13C NMR (100 MHz, CDCl3) δ 157.4, 156.9, 138.0, 136.1,
135.7, 128.7, 128.6, 128.5, 128.2, 127.9, 127.8, 72.8, 69.6, 68.4/68.1,
67.9, 62.2, 58.4/56.9, 29.4, 24.7 ppm; HPLC with an AS-H column (n-
hexane/i-PrOH = 95:5), 1.0 mL/min; major enantiomer tR = 83.5 min,
minor enantiomer tR = 74.3 min; HRMS (ESI) [M + H]+ calcd. for
[C28H33N2O6] 493.2339, found 493.2328.
(R)-Diethyl 1-(1-hydroxyheptan-4-yl)hydrazine-1,2-dicar-
23
boxylate (13c). Colorless oil (51 mg, 70%): [α]D = 3.6 (c = 1.0
in CHCl3); IR (thin film, KBr) 3466, 3283, 2960, 2933, 1711, 1417,
1
1257, 1060, 760 cm−1; H NMR (400 MHz, CDCl3) δ 6.35 (brm,
1H), 4.21−4.03 (m, 5H), 3.67−3.59 (m, 2H), 1.80−1.42 (m, 8H),
1.29−1.25 (m, 6H), 0.90 (t, J = 6.8 Hz, 3H) ppm; 13C NMR (100
MHz, CDCl3) δ 157.5/157.1, 156.5, 62.4, 62.4, 62.1, 58.4/57.5, 34.9,
29.5, 28.7, 19.7, 14.5, 14.4, 13.9 ppm; HRMS (ESI) [M + H]+ calcd.
for [C13H27N2O5] 291.1920, found 291.1920.
(R)-Diethyl 1-(8-cyano-1-hydroxyoctan-4-yl)hydrazine-1,2-
23
dicarboxylate (13j). Colorless oil (36 mg, 44%): [α]D = 8.9 (c =
1.62 in CHCl3); IR (thin film, KBr) 3473, 3285, 2934, 2869, 2246,
1
(R)-Diethyl 1-(1-hydroxyundecan-4-yl)hydrazine-1,2-dicar-
1752, 1708, 1417, 1260, 1233, 1058, 761 cm−1; H NMR (400 MHz,
23
boxylate (13d). Colorless oil (62 mg, 72%): [α]D = 3.8 (c = 1.58
CDCl3) δ 6.74 (brm, 1H), 4.19−4.00 (m, 5H), 3.65−3.58 (m, 2H),
2.33 (t, J = 6.6 Hz, 2H), 2.10 (brs, 1H), 1.91−1.24 (m, 10H), 1.26 (t, J
= 7.0 Hz, 6H) ppm; 13C NMR (100 MHz, CDCl3) δ 157.6, 157.1/
156.7, 119.9, 62.8, 62.6, 62.2, 58.6/57.4, 32.2/31.9, 29.3/28.8, 25.7,
25.3, 17.1, 14.6 ppm; HRMS (ESI) [M + H]+ calcd. for [C15H28N3O5]
330.2029, found 330.2030.
General Procedure for Preparation of Esters 22a−e, 22g,
22j. To alcohol 13 (1 equiv) in CH2Cl2 (0.1 M) was added Et3N (1.3
equiv) and 4-chlorobenzoyl chloride (1.3 equiv). After disappearance
of alcohol by TLC, the solvent was removed under reduced pressure,
and the product was purified by flash chromatography (EtOAc/
petroleum ether).
in CHCl3); IR (thin film, KBr) 3453, 3277, 2926, 2856, 1757, 1712,
1
1416, 1260, 1062, 760 cm−1; H NMR (400 MHz, CDCl3) δ 6.44
(brm, 1H), 4.18−3.99 (m, 5H), 3.66−3.57 (m, 2H), 1.99−1.24 (m,
16H), 1.28−1.24 (m, 6H), 0.86 (t, J = 6.6 Hz, 3H) ppm; 13C NMR
(100 MHz, CDCl3) δ 157.6/157.2, 157.1/156.7, 62.5, 62.2, 62.1, 58.9/
57.9, 32.8, 31.9, 29.5, 29.4, 28.8, 26.6, 22.8, 14.6/14.5, 14.2 ppm;
HRMS (ESI) [M + H]+ calcd. for [C17H35N2O5] 347.2546, found
347.2555.
(S)-Diethyl 1-(1-hydroxy-6-methylheptan-4-yl)hydrazine-
23
1,2-dicarboxylate (13e). Colorless oil (43 mg, 57%): [α]D = 1.9
(c = 2.12 in CHCl3); IR (thin film, KBr) 3465, 3284, 2957, 2870,
1756, 1711, 1417, 1259, 1062, 760 cm−1; 1H NMR (400 MHz,
CDCl3) δ 6.39 (brm, 1H), 4.19−4.17 (m, 5H), 3.67−3.58 (m, 2H),
1.96−1.11 (m, 8H), 1.29−1.25 (m, 6H), 0.90−0.88 (m, 6H) ppm; 13C
NMR (100 MHz, CDCl3) δ 157.8, 157.3/156.7, 62.8, 62.7, 62.5, 57.1/
56.0, 42.3/42.0, 29.8/29.3, 25.4/25.2, 23.6, 22.5/22.2, 14.8 ppm;
HRMS (ESI) [M + H]+ calcd. for [C14H29N2O5] 305.2076, found
305.2072.
(R)-Diethyl 1-(5-((4-chlorobenzoyl)oxy)pentan-2-yl)-
hydrazine-1,2-dicarboxylate (22a). Colorless oil (62 mg, 78%):
22
[α]D = −8.8 (c = 1.02 in CHCl3); IR (thin film, KBr) 3300, 2980,
1
2934, 1756, 1720, 1595, 1405, 1274, 1172, 760 cm−1; H NMR (400
MHz, CDCl3) δ 7.96 (d, J = 8.4 Hz, 2H), 7.40 (d, J = 8.4 Hz, 2H),
6.28 (brs, 1H), 4.31 (t, J = 6.4 Hz, 2H), 4.32−4.17 (m, 5H), 1.90−
1.67 (m, 3H), 1.48 (brs, 1H), 1.28−1.23 (m, 6H), 1.60 (d, J = 6.8 Hz,
3H) ppm; 13C NMR (100 MHz, CDCl3) δ 165.9, 157.4, 156.1, 139.4,
131.1, 128.9, 128.8, 65.2, 62.5, 62.1, 53.4, 30.6, 25.8, 18.3, 14.6, 14.5
ppm; HPLC with an AS-H column (n-hexane/i-PrOH = 95:5), 1.0
mL/min; major enantiomer tR = 28.7 min, minor enantiomer tR = 38.9
min; HRMS (ESI) [M + H]+ calcd. for [C18H26ClN2O6] 401.1479,
found 401.1477.
(S)-Diethyl 1-(5-hydroxy-1-phenylpentan-2-yl)hydrazine-
23
1,2-dicarboxylate (13f). Colorless oil (41 mg, 49%): [α]D
=
14.4 (c = 0.94 in CHCl3); IR (thin film, KBr) 3285, 2981, 2929, 1712,
1414, 1291, 1233, 1063, 758, 702 cm−1; 1H NMR (400 MHz, CDCl3)
δ 7.31−7.19 (m, 5H), 6.31 (brm, 1H), 4.58−4.07 (m, 5H), 3.67−3.58
(m, 2H), 2.85−2.79 (m, 2H), 2.05−1.51 (m, 4H), 1.30−1.18 (m, 7H)
ppm; 13C NMR (100 MHz, CDCl3) δ 157.8/157.2, 156.7/156.4,
138.5, 128.9, 128.7, 126.7, 62.6, 62.4, 60.3, 39.6.1/39.3, 29.5, 28.3, 14.6
ppm; HPLC with an AS-H column (n-hexane/i-PrOH = 95:5), 1.0
mL/min; major enantiomer tR = 39.6 min, minor enantiomer tR = 33.5
min; HRMS (ESI) [M + H]+ calcd. for [C17H27N2O5] 339.1920,
found 339.1920.
(R)-Diethyl 1-(6-((4-chlorobenzoyl)oxy)hexan-3-yl)-
hydrazine-1,2-dicarboxylate (22b). Colorless oil (42 mg, 84%):
23
[α]D = −9.6 (c = 0.7 in CHCl3); IR (thin film, KBr) 3296, 2978,
1
2934, 1757, 1718, 1595, 1405, 1274, 1093, 1015, 928 cm−1; H NMR
(400 MHz, CDCl3) δ 7.97 (d, J = 8.4 Hz, 2H), 7.40 (d, J = 8.4 Hz,
2H), 6.13 (brs, 1H), 4.32 (t, J = 6.4 Hz, 2H), 4.19−3.97 (m, 5H), 1.99
(brs, 1H), 1.82 (brs, 1H), 1.53−1.41 (m, 4H), 1.29−1.21 (m, 6H),
0.90 (brs, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ 165.9, 157.5/
157.2, 156.8/156.7, 139.4, 131.1, 129.1, 128.8, 65.2, 62.5, 62.2, 60.3/
59.4, 29.0/28.9, 25.9, 25.7/25.6, 14.7, 14.6, 11.2 ppm; HPLC with an
AS-H column (n-hexane/i-PrOH = 95:5), 1.0 mL/min; major
enantiomer tR = 15.9 min, minor enantiomer tR = 25.2 min; HRMS
(ESI) [M + H]+ calcd. for [C19H28ClN2O6] 415.1636, found 415.1638.
(R)-Diethyl 1-(1-((4-chlorobenzoyl)oxy)heptan-4-yl)-
hydrazine-1,2-dicarboxylate (22c). Colorless oil (82 mg, 91%):
(S)-Diethyl 1-(5-hydroxy-1-(methylthio)pentan-2-yl)-
hydrazine-1,2-dicarboxylate (13g). Colorless oil (35 mg, 45%):
23
[α]D = 31.5 (c = 1.07 in CHCl3); IR (thin film, KBr) 3465, 3284,
1
2980, 2922, 2871, 1712, 1414, 1331, 1249, 1063, 760 cm−1; H NMR
(400 MHz, CDCl3) δ 6.47 (brm, 1H), 4.39−4.16 (m, 5H), 3.68−3.60
(m, 2H), 2.58 (brs, 2H), 2.08 (s, 3H), 2.02 (brs, 1H), 1.83−1.52 (m,
3H), 1.27 (t, J = 7.0 Hz, 6H) ppm; 13C NMR (100 MHz, CDCl3) δ
157.8/157.3, 156.9/156.8, 62.9, 62.7, 62.3, 57.3/55.8, 37.3/36.7, 29.6,
28.3, 15.5/15.2, 14.6 ppm; HRMS (ESI) [M + H]+ calcd. for
[C12H25N2O5S] 309.1484, found 309.1492.
24
[α]D = −10.5 (c = 1.4 in CHCl3); IR (thin film, KBr) 3293, 2961,
1
2933, 1757, 1717, 1274, 1093, 1015, 851 cm−1; H NMR (400 MHz,
(R)-Dibenzyl 1-(1-hydroxyheptan-4-yl)hydrazine-1,2-dicar-
24
boxylate (13h). White solid (46 mg, 44%): mp 83−84 °C; [α]D
CDCl3) δ 7.96 (d, J = 8.4 Hz, 2H), 7.39 (d, J = 8.4 Hz, 2H), 6.25−6.18
(brm, 1H), 4.38−4.16 (m, 5H), 4.31 (t, J = 6.4 Hz, 2H), 1.99 (brs,
1H), 1.81−1.50 (m, 7H), 1.41−1.28 (m, 6H), 0.90 (t, J = 6.4 Hz, 3H)
ppm; 13C NMR (100 MHz, CDCl3) δ 165.9, 157.4/157.1, 156.8/
156.5, 139.4, 131.1, 129.0, 128.8, 65.2, 62.7/62.5, 62.2, 58.1/57.3, 34.9,
29.2, 25.9, 19.7, 14.6, 14.5, 14.0 ppm; HPLC with an AS-H column (n-
hexane/i-PrOH = 95:5), 1.0 mL/min; major enantiomer tR = 13.2 min,
minor enantiomer tR = 18.9 min; HRMS (ESI) [M + H]+ calcd. for
[C20H30ClN2O6] 429.1792, found 429.1788.
= 4.4 (c = 1.6 in CHCl3); IR (thin film, KBr) 3280, 3033, 2958, 2872,
1711, 1455, 1413, 1258, 1216, 1050, 740, 697 cm−1; H NMR (400
1
MHz, CDCl3) δ 7.31 (brs, 10H), 6.81 (brm, 1H), 5.68−4.65 (m, 4H),
4.23−4.05 (m, 1H), 3.57−3.34 (m, 2H), 2.10 (brs, 1H), 1.62−1.23
(m, 7H), 0.89−0.71 (m, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ
157.3/157.0, 156.9/156.4, 136.2/136.0, 135.7, 128.6, 128.7, 128.6,
128.5, 128.3, 128.2, 127.8, 68.4/68.1, 67.9, 62.5, 59.0/57.9, 34.9, 29.5,
28.7, 19.7, 14.0 ppm; HPLC with an AD-H column (n-hexane/i-PrOH
= 90:10), 1.0 mL/min; major enantiomer tR = 23.0 min, minor
enantiomer tR = 28.3 min; HRMS (ESI) [M + H]+ calcd. for
[C23H31N2O5] 415.2233, found 415.2228.
(R)-Diethyl 1-(1-((4-chlorobenzoyl)oxy)undecan-4-yl)-
hydrazine-1,2-dicarboxylate (22d). Colorless oil (33 mg, 49%):
23
[α]D = −8.8 (c = 1.0 in CHCl3); IR (thin film, KBr) 3299, 2957,
2928, 2856, 1759, 1721, 1405, 1274, 1228, 1118, 1104, 1093, 761
(S)-Dibenzyl 1-(1-(benzyloxy)-5-hydroxypentan-2-yl)-
hydrazine-1,2-dicarboxylate (13i). Colorless oil (46 mg, 37%):
[α]D26 = 7.2 (c = 1.7 in CHCl3); IR (thin film, KBr) 3279, 3032, 2942,
1
cm−1; H NMR (400 MHz, CDCl3) δ 7.97 (d, J = 8.4 Hz, 2H), 7.40
(d, J = 8.4 Hz, 2H), 6.13 (brm, 1H), 4.33−4.05 (m, 5H), 4.31 (t, J =
6.4 Hz, 2H), 2.00−1.25 (m, 16H), 1.29−1.25 (m, 6H), 0.87 (t, J = 6.8
1
2867, 1713, 1498, 1454, 1411, 1218, 1091, 739, 697 cm−1; H NMR
D
dx.doi.org/10.1021/jo3017007 | J. Org. Chem. XXXX, XXX, XXX−XXX